Switch to:
GuruFocus has detected 2 Warning Signs with Repros Therapeutics Inc $RPRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Repros Therapeutics Inc (NAS:RPRX)
EV-to-EBITDA
-1.29 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Repros Therapeutics Inc's enterprise value is $22.26 Mil. Repros Therapeutics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2016 was $-17.27 Mil. Therefore, Repros Therapeutics Inc's EV/EBITDA ratio for today is -1.29.

RPRX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -31.5   Max: -0.2
Current: -1.28

-31.5
-0.2

During the past 13 years, the highest EV/EBITDA Ratio of Repros Therapeutics Inc was -0.20. The lowest was -31.50. And the median was -5.10.

RPRX's EV-to-EBITDA is ranked lower than
99.99% of the 466 Companies
in the Global Biotechnology industry.

( Industry Median: 17.12 vs. RPRX: -1.28 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Repros Therapeutics Inc's stock price is $0.95. Repros Therapeutics Inc's earnings per share for the trailing twelve months (TTM) ended in Dec. 2016 was $-0.70. Therefore, Repros Therapeutics Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Repros Therapeutics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=22.256/-17.267
=-1.29

Repros Therapeutics Inc's current Enterprise Value is $22.26 Mil.
Repros Therapeutics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2016 was -4.842 (Mar. 2016 ) + -4.279 (Jun. 2016 ) + -4.168 (Sep. 2016 ) + -3.978 (Dec. 2016 ) = $-17.27 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Repros Therapeutics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=0.95/-0.7
=

Repros Therapeutics Inc's share price for today is $0.95.
Repros Therapeutics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2016 was -0.2 (Mar. 2016 ) + -0.18 (Jun. 2016 ) + -0.17 (Sep. 2016 ) + -0.15 (Dec. 2016 ) = $-0.70.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Repros Therapeutics Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda -6.45-5.63-0.68-5.17-4.44-13.06-12.21-6.02-0.28-1.47

Repros Therapeutics Inc Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
ev2ebitda -5.60-6.02-5.30-4.52-5.09-0.28-0.30-1.21-2.15-1.47
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK